Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
OWLT
Owlet, Inc.
CAPPED RATING
Owlet, Inc. (OWLT) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (D+).
Quantitative Factor Evaluation • Updated
Overall Rating
2.4
/ 5.0
C
Value
B
Factor Score
3.2
/ 5.0
Growth
C
Factor Score
2.2
/ 5.0
Profitability
C
Factor Score
2.4
/ 5.0
Momentum
D+
Factor Score
1.6
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
15.6
EV / EBITDA
-12.8
Rev Growth YoY
29.9%
Gross Margin
54.6%
Price Return 3M
-43.7%
Price Return 12M
-68.7%
Catalyst Signal
0.00
Market Cap
$100.5M
TTM Revenue
$114.4M
Price / Sales
0.9
ROE
N/A
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | B (3.2) | C (2.2) | C (2.4) | D+ (1.6) | C+ (2.6) | C (2.4) |
| 2026-11-07 | B- (3.1) | C (2.3) | C (2.4) | C- (2.1) | C+ (2.7) | C+ (2.5) |
| 2026-10-31 | B (3.2) | C (2.3) | C+ (2.6) | C (2.3) | C+ (2.7) | C+ (2.6) |
| 2026-10-24 | B- (3.1) | C (2.2) | C+ (2.5) | C- (2.1) | C+ (2.6) | C+ (2.5) |
| 2026-10-17 | B- (3.1) | C (2.2) | C+ (2.5) | D+ (1.7) | C+ (2.6) | C (2.5) |
Page
1
of
4